MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Hemispherx BioPharma Company Profile (NYSE:HEB)

Consensus Ratings for Hemispherx BioPharma (NYSE:HEB) (?)
Ratings Breakdown: 1 Strong Buy Rating(s)
Consensus Rating:Strong Buy (Score: 4.00)
Consensus Price Target: $1.45 (1,107.33% upside)

Analysts' Ratings History for Hemispherx BioPharma (NYSE:HEB)
DateFirmActionRatingPrice TargetActions
4/2/2015Midtown PartnersInitiated CoverageStrong-Buy$1.45View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/13/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha